Ranizurel 0.5mg Injection

Discover how Ranizurel 0.5mg Injection, formulated by Reliance Life Sciences with Ranibizumab (0.5mg), can assist with Diabetic eye disease,Wet age-related macular degeneration,Macular edema due to retinal vein occlusion. This page provides a comprehensive overview of this medication, including its primary applications and further detailed information to support your understanding. Feel free to add it to your favorites or compare it with other available options.

MRP: ₹ 19990
Packing: 1.0 Injection in 1 vial
Salt Combination: Ranibizumab (0.5mg)
Brand: Reliance Life Sciences
Uses: Diabetic eye disease,Wet age-related macular degeneration,Macular edema due to retinal vein occlusion

Description

Ranizurel 0.5mg Injection is used for the treatment of eye diseases which are caused by diabetes, macular degeneration, and macular swelling
It reduces the abnormal growth and leakage of blood vessels in the eye that can cause vision loss
Ranizurel 0.5mg Injection is administered directly into the eyeball by an eye specialist
You should not self administer this medicine at home.
The common side effects include conjunctival hemorrhage, eye pain, eye floaters, increased intraocular pressure, and eye inflammation
If these side effects get worse or persist for a longer duration, inform your doctor
It is not advised to drive after administration of this injection as it may cause temporary blurring of vision.
There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg
Please contact your prescribing doctor to know more about the same
You may also call on (1800-102-1618) for more details.

Cautions

Liver:	SAFE IF PRESCRIBED: Ranizurel 0.5mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Ranizurel 0.5mg Injection may not be needed in these patients. Please consult your doctor.
Kidney:	SAFE IF PRESCRIBED: Ranizurel 0.5mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Ranizurel 0.5mg Injection may not be needed in these patients. Please consult your doctor.
Driving:	UNSAFE: Ranizurel 0.5mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Breast feeding:	SAFE IF PRESCRIBED: Ranizurel 0.5mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnency:	CONSULT YOUR DOCTOR: Ranizurel 0.5mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Ranizurel 0.5mg Injection. Please consult your doctor.
Drug Action:	Vascular endothelial growth factor (VEGF) inhibitor for AMD
Therapeutic class:	OPHTHAL
Habit Forming:	No
Chemical Class:	Monoclonal antibody (mAb)